Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 28;28(13):5061.
doi: 10.3390/molecules28135061.

Foegraecumoside O and P, a Pair of Triterpenoid Saponins with a 4/5/6 Fused Tricyclic Oleanane Carbon Skeleton from Lysimachia foenum-graecum Hance

Affiliations

Foegraecumoside O and P, a Pair of Triterpenoid Saponins with a 4/5/6 Fused Tricyclic Oleanane Carbon Skeleton from Lysimachia foenum-graecum Hance

Lumei Dai et al. Molecules. .

Abstract

Lysimachia foenum-graecum Hance (Primulaceae) is a medicinal plant used for cold, pain, ascariasis, etc., in China. Triterpenoid saponins have been found to be the main components of this genus. In this work, a pair of oleanane-type triterpenoid saponins with an unprecedented 4/5/6 fused tricyclic skeleton, foegraecumoside O (1) and foegraecumoside P (2) were isolated from the butanol fraction of the aerial parts of L. foenum-graecum. Their structures were determined using chemical methods and extensive spectroscopic analyses, along with quantum chemical calculations. Compound 2 displayed moderate cytotoxicity against HepG2, MGC-803, T24, NCI-H460, A549, and A549/CDDP (drug-resistant lung-cancer cell line) with IC50 at 12.4-19.2 μM in an MTT assay, comparing with the positive control doxorubicin, which had IC50 at 0.53-4.92 μM, but was inactive for A549/CDDP. Furthermore, a possible biosynthetic pathway for forming compounds 1 and 2 was proposed.

Keywords: Lysimachia; Lysimachia foenum-graecum; Primulaceae; cytotoxicity; triterpenoids.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Chemical structures of compounds 1 and 2.
Figure 2
Figure 2
The key COSY, HMBC, and NOESY correlations of compound 1.
Figure 3
Figure 3
Key NOESY correlations of compound 2.
Figure 4
Figure 4
Linear regression fitting of computed 13C NMR chemical shifts of compounds 1 (A,C) and 2 (B,D), with experimental values of compounds 1 (A,B) and 2 (C,D).
Figure 5
Figure 5
Linear regression fitting of computed 1H NMR chemical shifts of compounds 1 (A,C) and 2 (B,D), with experimental values of compounds 1 (A,B) and 2 (C,D).
Scheme 1
Scheme 1
Hypothetical biogenetic pathway for compounds 1 and 2.

Similar articles

Cited by

References

    1. Siegel R.L., Miller K.D., Wagle N.S., Jemal A. Cancer Statistics, 2023. CA Cancer J. Clin. 2023;73:17–48. doi: 10.3322/caac.21763. - DOI - PubMed
    1. Vasan N., Baselga J., Hyman D.M. A View on Drug Resistance in Cancer. Nature. 2019;575:299–309. doi: 10.1038/s41586-019-1730-1. - DOI - PMC - PubMed
    1. Housman G., Byler S., Heerboth S., Lapinska K., Longacre M., Snyder N., Sarkar S. Drug Resistance in Cancer: An Overview. Cancers. 2014;6:1769–1792. doi: 10.3390/cancers6031769. - DOI - PMC - PubMed
    1. Hu C., Kelso S. Primulaceae. Flora China. 1996;5:39–189.
    1. Committee of Chinese Materia Medica. National Administration of Traditional Chinese Medicine . Chinese Materia Medica. Shanghai Science and Technology Press; Shanghai, China: 1999. Lysimachia foenum-graecum Hance; pp. 5364–5366.

LinkOut - more resources